Search Results for "Number Of Deaths Prevnar"
Matching Channels
Coronavirus were first identified in the 1960s, and were named after the crown-like projections on the surface of the virus. They cause respiratory infections in both humans and animals. Coronavir...
Tuberculosis Vaccines and Therapeutics
The WHO estimates that the largest number of new tuberculosis (TB) cases in 2008 occurred in the South-East Asia Region, which accounted for 34% of incident cases globally. However, the estimated inci...
MatBA - Mature B-cell neoplasm array
Mature B-cell neoplasms arise in B-cells that have entered germinal centers within lymph nodes as part of the immune response. They display great heterogeneity at the clinical, pathologic, and genet...
The pancreas secretes a number of important hormones into the digestive tract and the blood stream. Cancers are most commonly exocrine than endocrine (neuroendocrine) tumors. Functional tumors secre...
Tumor markers are substances produced by tumor cells or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. These substances can be found in the blood, in t...
Matching News
Prevnar-13 OK'd for Older Kids, Teens
(MedPage Today) -- The Prevnar-13 multivalent pneumococcal vaccine is now FDA-approved for unvaccinated children 6 to 17, its manufacturer announced.
Pfizer Receives FDA Approval For The Use Of Prevnar 13 In Vaccine-Naive Children And ...
Prevnar 13 is the First and Only Pneumococcal Conjugate Vaccine Approved for This Age Group
FDA OKs wider use of Pfizer's Prevnar 13 vaccine
The FDA approved the use of Pfizer's pneumococcal conjugate vaccine Prevnar 13 in patients ages 6 to 17. -More-
September 14, 2012 Approval Letter - Prevnar 13
Proposed revisions for the How Supplied/Storage and Handling section of the package insert and for the carton. These changes include the new presentation for Prevnar 13® as a single prefilled syringe...
Pfizer's Prevnar 13: The World's Leading Vaccine And Its Competitors
By Peter Geschek:Prevnar 13 from Pfizer's (PFE) Wyeth division is an enormously successful pneumococcal conjugate vaccine, currently the best-selling vaccine in the world. Prevnar 13 was first introdu...
Pfizer gets broader Prevnar 13 vaccine approval
Pfizer Inc. said Tuesday that European Union regulators approved the use of its Prevnar 13 vaccine in children and adolescents aged 6 to 17.The vaccine protects against 13 strains of pneumococcal bac...
Pfizer unveil results of Prevnar 13 in adults with HIV phase 3 study
Pfizer have unveiled the results from a Phase 3 study that trialled pneumococcal vaccine Prevnar 13 in adults infected with human immunodeficiency virus (HIV). In [...]
Pfizer Prevnar vaccine wins approval for ages 6-17
(Reuters) - Pfizer Inc on Friday said U.S. regulators had approved wider use of its Prevnar 13 vaccine to prevent infections with pneumococcal bacteria, for children and adolescents aged 6 years to 17...
Matching PubMed Articles
An expanded pneumococcal vaccine (prevnar 13) for infants and children.
The incidence of invasive pneumococcal disease (IPD), caused by the approximately 91 serotypes of Streptococcus pneumoniae (PN), varies geographically and temporally as a result of changing epidemiolo...
Estimates of deaths associated with seasonal influenza --- United States, 1976--2007.
Influenza infections are associated with thousands of deaths every year in the United States, with the majority of deaths from seasonal influenza occurring among adults aged =65 years. For several dec...
ABSTRACT: OBJECTIVE: The purpose of this paper was to compare two mathematical procedures to estimate the annual attributable number of deaths (the Allison et al procedure and the Mokdad et al procedu...
Decrease in Shigellosis-related Deaths without Shigella spp.-specific Interventions, Asia.
In 1999, a review of the literature for 1966-1997 suggested that ≊1.1 million persons die annually of shigellosis, including ≊880,000 in Asia. Our recent review of the literature for 1990-2009 ind...
